- Home
- PSTV vs NDRA Comparison
PSTV vs NDRA Comparison
Compare PSTV & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSTV
- NDRA
- Stock Information
- Founded
- PSTV 1996
- NDRA 2007
- Country
- PSTV United States
- NDRA United States
- Employees
- PSTV N/A
- NDRA N/A
- Industry
- PSTV Medical/Dental Instruments
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- PSTV Health Care
- NDRA Health Care
- Exchange
- PSTV Nasdaq
- NDRA Nasdaq
- Market Cap
- PSTV 2.1M
- NDRA 2.1M
- IPO Year
- PSTV N/A
- NDRA 2017
- Fundamental
- Price
- PSTV $0.79
- NDRA $3.98
- Analyst Decision
- PSTV Strong Buy
- NDRA Strong Buy
- Analyst Count
- PSTV 3
- NDRA 1
- Target Price
- PSTV $11.50
- NDRA $50.00
- AVG Volume (30 Days)
- PSTV 3.8M
- NDRA 355.0K
- Earning Date
- PSTV 05-14-2025
- NDRA 05-13-2025
- Dividend Yield
- PSTV N/A
- NDRA N/A
- EPS Growth
- PSTV N/A
- NDRA N/A
- EPS
- PSTV N/A
- NDRA N/A
- Revenue
- PSTV $5,824,000.00
- NDRA N/A
- Revenue This Year
- PSTV $13.26
- NDRA N/A
- Revenue Next Year
- PSTV $24.59
- NDRA N/A
- P/E Ratio
- PSTV N/A
- NDRA N/A
- Revenue Growth
- PSTV 18.54
- NDRA N/A
- 52 Week Low
- PSTV $0.24
- NDRA $2.97
- 52 Week High
- PSTV $2.67
- NDRA $665.00
- Technical
- Relative Strength Index (RSI)
- PSTV 47.37
- NDRA 51.65
- Support Level
- PSTV $0.61
- NDRA $3.28
- Resistance Level
- PSTV $1.22
- NDRA $3.98
- Average True Range (ATR)
- PSTV 0.13
- NDRA 0.92
- MACD
- PSTV 0.02
- NDRA 0.02
- Stochastic Oscillator
- PSTV 29.16
- NDRA 31.76
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.